Answer
Somatrogon treatment may reduce insulin sensitivity and cause hyperglycaemia; additional monitoring should be considered with glucose intolerance or other diabetes risk factors, and diabetes medicines may need adjustment in patients with diabetes.
Sources for this answer
- Ngenla 60 mg solution for injection in pre-filled penPfizer Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 7Document updated
Sources checked